Rivaroxaban proves superior to heparin in preventing blood clots after common orthopaedic surgeries

The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopaedic surgery and requiring immobilisation, in comparison with enoxaparin, another